SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001193125-14-383457
Filing Date
2014-10-27
Accepted
2014-10-27 17:18:01
Documents
8
Effectiveness Date
2014-10-27

Document Format Files

Seq Description Document Type Size
1 DFAN14A d811727ddfan14a.htm DFAN14A 53092
2 GRAPHIC g811727img01.jpg GRAPHIC 102564
3 GRAPHIC g811727img02.jpg GRAPHIC 115968
4 GRAPHIC g811727img03.jpg GRAPHIC 112328
5 GRAPHIC g811727img04.jpg GRAPHIC 112465
6 GRAPHIC g811727img05.jpg GRAPHIC 120142
7 GRAPHIC g811727img06.jpg GRAPHIC 118617
8 GRAPHIC g811727img08.jpg GRAPHIC 103870
  Complete submission text file 0001193125-14-383457.txt   1138493
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Subject) CIK: 0000850693 (see all company filings)

IRS No.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-10269 | Film No.: 141175168
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019 212-813-3700
Pershing Square Capital Management, L.P. (Filed by) CIK: 0001336528 (see all company filings)

IRS No.: 383694136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A